Depletion‐assisted multiplexed cell‐free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles
Clinical and Translational Medicine · 2024-07 · 14 (7)
DOI: 10.1002/ctm2.1760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 19.07.2024. Verfasst von Hongke Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Cell-Free Nucleic Acids, Sequence Analysis, RNA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research, National Key Research and Development Plan of China.
Abstract (Originalsprache)
Background
Cell‐free long RNAs in human plasma and extracellular vesicles (EVs) have shown promise as biomarkers in liquid biopsy, despite their fragmented nature.
Methods
To investigate these fragmented cell‐free RNAs (cfRNAs), we developed a cost‐effective cfRNA sequencing method called DETECTOR‐seq (depletion‐assisted multiplexed cell‐free total RNA sequencing). DETECTOR‐seq utilised a meticulously tailored set of customised guide RNAs to remove large amounts of unwanted RNAs (i.e., fragmented ribosomal and mitochondrial RNAs) in human plasma. Early barcoding strategy was implemented to reduce costs and minimise plasma requirements.
Results
Using DETECTOR‐seq, we conducted a comprehensive analysis of cell‐free transcriptomes in both whole human plasma and EVs. Our analysis revealed discernible distributions of RNA types in plasma and EVs. Plasma exhibited pronounced enrichment in structured circular RNAs, tRNAs, Y RNAs and viral RNAs, while EVs showed enrichment in messenger RNAs (mRNAs) and signal recognition particle RNAs (srpRNAs). Functional pathway analysis highlighted RNA splicing‐related ribonucleoproteins (RNPs) and antimicrobial humoral response genes in plasma, while EVs demonstrated enrichment in transcriptional activity, cell migration and antigen receptor‐mediated immune signals. Our study indicates the comparable potential of cfRNAs from whole plasma and EVs in distinguishing cancer patients (i.e., colorectal and lung cancer) from healthy donors. And microbial cfRNAs in plasma showed potential in classifying specific cancer types.
Conclusions
Our comprehensive analysis of total and EV cfRNAs in paired plasma samples provides valuable insights for determining the need for EV purification in cfRNA‐based studies. We envision the cost effectiveness and efficiency of DETECTOR‐seq will empower transcriptome‐wide investigations in the fields of cfRNAs and liquid biopsy. Keypoints DETECTOR‐seq (depletion‐assisted multiplexed cell‐free total RNA sequencing) enabled efficient and specific depletion of sequences derived from fragmented ribosomal and mitochondrial RNAs in plasma. Distinct human and microbial cell‐free RNA (cfRNA) signatures in whole Plasma versus extracellular vesicles (EVs) were revealed. Both Plasma and EV cfRNAs were capable of distinguishing cancer patients from normal individuals, while microbial RNAs in Plasma cfRNAs enabled better classification of cancer types than EV cfRNAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University, Beijing, China.
- Institute for Precision Medicine, Tsinghua University, Beijing, China.
- Geneplus-Beijing Institute, Beijing, China.
- Tianjin Third Central Hospital, Tianjin, China.
- Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, China.
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), MST State Key Laboratory of Complex Severe and Ra…
ORCID-Profile: Hongke Wang, Jiuliang Zhao
Förderung
- National Natural Science Foundation of China
- Capital's Funds for Health Improvement and Research
- National Key Research and Development Plan of China
- Tsinghua University Guoqiang Institute
- Tsinghua University Initiative Scientific Research Program of Precision Medicine
- Institute of Health and Medicine, Hefei Comprehensive National Science Center
- Bayer Micro-funding
- Bio-Computing Platform of Tsinghua University Branch of China National Center for Protein Sciences
Zitieren
APA
Wang, H., Zhan, Q., Ning, M., Guo, H., Wang, Q., Zhao, J., Bao, P., Xing, S., Chen, S., Zuo, S., Xia, X., Li, M., Wang, P., & Lu, Z. J. (2024). Depletion‐assisted multiplexed cell‐free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles. Clinical and Translational Medicine, 14(7). https://doi.org/10.1002/ctm2.1760
Vancouver
Wang H, Zhan Q, Ning M, Guo H, Wang Q, Zhao J, et al. Depletion‐assisted multiplexed cell‐free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles. Clinical and Translational Medicine. 2024;14(7). doi:10.1002/ctm2.1760
BibTeX
@article{Wang2024,
author = {Wang, Hongke and Zhan, Qing and Ning, Meng and Guo, Hongjie and Wang, Qian and Zhao, Jiuliang and Bao, Pengfei and Xing, Shaozhen and Chen, Shanwen and Zuo, Shuai and Xia, Xuefeng and Li, Mengtao and Wang, Pengyuan and Lu, Zhi John},
title = {Depletion‐assisted multiplexed cell‐free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {7},
doi = {10.1002/ctm2.1760}
}
EUVIMED